And what they found was that people who lived to 90 or 100 were more likely to have daf-2 mutations -- that is, changes in the gene that encodes the receptor for IGF-1.
Ze vonden dat mensen die leefden tot 90 of 100 meer kans hadden om daf-2-mutaties te hebben - dat wil zeggen, veranderingen in het gen dat codeert voor de receptor IGF-1.